Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (3348)	4/9/1998 12:54:00 PM
From: Dauntless	Respond to of 7041

Hank, we could dance forever I could counter a few of your statements - but it would just continue this merry go round. Still boils down to a matter of opinion, IMHO <g>. I believe Zona's clinical data to be presented in early June at AUA. Hopefully, NDA will have been filed by then. Good luck!!

To: Hank who wrote (3348)	4/11/1998 8:48:00 AM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Hank, While I agree that the difference in the delivery system was so significant between Muse and Caverjet, and then between Viagra and the prior delivery systems, I do think hat a 15 minute versus an hour response time is an important difference. The question in my mind is whether Vasomax works at all, but if it does work, I think people will prefer the faster response time. The interest in Viagra is occurring despite the long response time, because so many people don't want to deal with the previous delivery systems, and because of the marketing clout that PFE has exercised. It will be hard to take on Viagra because of the fabulous image they've created for it, but if there's a more effective drug, Viagra will be out of favor as quickly as it moved into favor, Linda